PubRank

R A Balk

Author PubWeight™ 105.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992 47.46
2 Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993 5.46
3 Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996 5.25
4 Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 1994 5.24
5 Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 1997 4.86
6 A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987 3.89
7 Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med 1989 3.41
8 The relation of pneumothorax and other air leaks to mortality in the acute respiratory distress syndrome. N Engl J Med 1998 3.40
9 Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997 2.84
10 A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med 1995 2.48
11 E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators. JAMA 2000 2.07
12 Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA 1994 1.64
13 Medical effectiveness of esophageal balloon pressure manometry in weaning patients from mechanical ventilation. Crit Care Med 1995 1.43
14 Sleep apnea and the Arnold-Chiari malformation. Am Rev Respir Dis 1985 1.42
15 Prognostic factors in sepsis: the cold facts. Crit Care Med 1992 1.40
16 Pneumothorax detection using computerised analysis of breath sounds. Med Biol Eng Comput 2002 1.03
17 Pneumothorax detection using pulmonary acoustic transmission measurements. Med Biol Eng Comput 2002 1.00
18 Indwelling small pleural catheter needle thoracentesis in the management of large pleural effusions. Chest 1997 0.99
19 The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis. J Rheumatol 1995 0.89
20 Prostaglandins, cyclo-oxygenase inhibitors, and thromboxane synthetase inhibitors in the pathogenesis of multiple systems organ failure. Crit Care Clin 1989 0.88
21 Noninvasive respiratory care unit. A cost effective solution for the future. Chest 1988 0.87
22 Nitric oxide in the pathogenesis of sepsis. Infect Dis Clin North Am 1999 0.87
23 Determination of cardiac output in critically ill patients by dual beam Doppler echocardiography. J Am Coll Cardiol 1989 0.85
24 New creations? Hastings Cent Rep 1991 0.83
25 Lymphocyte subpopulations of blood and alveolar lavage in blastomycosis. Chest 1985 0.82
26 Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men. Crit Care Med 1991 0.81
27 Hepatic dysfunction in the adult respiratory distress syndrome. Chest 1989 0.81
28 Dialysis-induced respiratory acidosis. Chest 1990 0.80
29 Central venous catheterization in the critically ill patient. Crit Care Clin 1992 0.80
30 The systemic inflammatory response syndrome. JAMA 1995 0.78
31 Breath sound changes associated with malpositioned endotracheal tubes. Med Biol Eng Comput 2005 0.78
32 Alveolar macrophage function in a canine model of endotoxin-induced lung injury. Am Rev Respir Dis 1986 0.77
33 Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 2009 0.76
34 Growth inhibition of Blastomyces dermatitidis in alveolar and peripheral macrophages from patients with blastomycosis. Am Rev Respir Dis 1987 0.76
35 Outcome of septic shock: location, location, location. Crit Care Med 1998 0.75
36 Radiographic patterns of pulmonary disease. Dis Mon 1997 0.75
37 Bronchoscopic procedures in the intensive care unit. Crit Care Clin 1995 0.75
38 Radiographic patterns of pulmonary disease. Curr Probl Diagn Radiol 1998 0.75
39 More on the vibrating footpad. Am Rev Respir Dis 1982 0.75
40 General approach to shock. Clin Geriatr Med 1994 0.75
41 Bacteremia during bronchoalveolar lavage. South Med J 1986 0.75
42 Ventilatory support in the management of septic patients. Crit Care Clin 1989 0.75